Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07555145 · ClinicalTrials.gov registry record · NA

Supporting Treatment Access and Recovery in Re-entry (STAR-R)

A NA study, sponsored by University of Massachusetts, Worcester.

Not yet
Registry status
NA
Development phase
240
Enrollment target

NCT07555145: Clinical Trial NA study, sponsored by University of Massachusetts, Worcester.

NCT07555145 is a NA study that has not yet begun recruiting, run by University of Massachusetts, Worcester. The registered enrollment target is 240 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07555145, a NA study, has not yet begun recruiting, sponsored by University of Massachusetts, Worcester.

NOT YET RECRUITING
Registry status
NA
Development phase
240 participants
Enrollment target

Study Summary

This application is aimed at testing a multicomponent intervention called "Maintaining Independence and Sobriety through Systems Integration, Outreach, and Networking-Criminal Justice (MISSION-CJ) or Peer Linkage Support post-release from two jails in Massachusetts for individuals with co-occurring substance use and mental health disorders (COD), given high rates of COD among incarcerated populations. The research will examine engagement in treatment, behavioral health outcomes, mediators and moderators, an economic analysis, and facilitators and barriers of MISSION-CJ implementation.

Primary Outcome

Measured by total days participating in each condition using fidelity logs adapted for each treatment arm.

Interventions

  • BEHAVIORAL Full MISSION-CJ
  • BEHAVIORAL Peer Linkage Support

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2026-08-01
Est. Completion 2030-08-31
Phase NA

What is known before NCT07555145 opens enrollment

NCT07555145 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).

The record links to 0 conditions, and to 2 interventions - of which Full MISSION-CJ is the first listed.

NCT07555145 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07555145 about?

NCT07555145 is a clinical study titled "Supporting Treatment Access and Recovery in Re-entry (STAR-R)". This application is aimed at testing a multicomponent intervention called "Maintaining Independence and Sobriety through Systems Integration, Outreach, and Networking-Criminal Justice (MISSION-CJ) or Peer Linkage Support post-release from two jails in Massachusetts for individuals with co-occurring ...

What is the current status of trial NCT07555145?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2026-08-01. Estimated completion is 2030-08-31.

What interventions are being tested in trial NCT07555145?

The interventions under investigation include: Full MISSION-CJ (BEHAVIORAL), Peer Linkage Support (BEHAVIORAL).

Who is sponsoring clinical trial NCT07555145?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07555145's enrollment target sits among peer trials

240 440th of 2000 higher than 1,542 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02855554 · 240 participants · NA

    Quantitative Cardiac Parametric Mapping

  • NCT03230565 · 240 participants · Phase 4

    Continuous Infusions vs Scheduled Bolus Infusions

  • NCT03399929 · 240 participants

    Traumatic Brain Injury and Stroke Long Term Outcome

  • NCT03583710 · 240 participants · Phase 3

    Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07555145, the US trial registry maintained by the National Library of Medicine. NCT07555145 (mid enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.